Alzheimers
10 Tampa Bay: Tampa researcher wants to study your brain, detect early signs of Alzheimer’s
The free clinical trial at Axiom Brain Health in Tampa works to detect early signs of Alzheimer’s and other cognitive diseases, even years before symptoms appear. Author: Hannah Dineen Published: 4:04 PM EST March 6, 2025 Updated: 8:52 PM EST March 6, 2025 TAMPA, Fla. — It’s estimated nearly 7 million people in the U.S. are living with Alzheimer’s disease. […]
National Citizen Scientist Awards Honor Outstanding Clinical Trial Volunteers for Their Role in Advancing Research
Washington D.C., Feb. 28, 2025 -The Global Alzheimer’s Platform Foundation® (GAP) proudly announced the 2024 National Citizen Scientist Awards® elevated honorees at their 2025 GAP-Net Site Optimization Conference in Miami, Florida. GAP’s Citizen Scientist Awards (CSA) celebrate the contributions of individuals who make a difference by volunteering in clinical trials for neurodegenerative diseases. This year’s […]
Staff Terminations at Department of Health & Human Services May Have Dire Consequences for the Future of Critical Research
Washington D.C., Feb. 18, 2025- The Global Alzheimer’s Platform Foundation ® (GAP) is gravely concerned over news of terminations of key leaders at the National Institute of Health and the Federal Drug Administration along with the firing of thousands of employees from the Department of Health and Human Services over the weekend. John Dwyer, the […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Roche for the Transformative Bio-Hermes-002 Study
Washington D.C., Feb. 18, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Roche to the Bio-Hermes-002 study. This collaboration will enhance this unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images as well as numerous races and ethnicities […]
CMO 360: A CMO’s Perspective on Designing Clinical Trials for a CNS Device
Ralph Kern, MD, MHSc, CMO of Cognito Therapeutics, discusses scaling up clinical trials, integrating patient centricity and transitioning from therapeutics to device treatments. February 13, 2025 Tell us about the scientific foundation behind the Spectris ADTM device. Our non-invasive investigational Spectris ADTM device evokes 40 Hz brain gamma oscillations through audiovisual stimulation. It’s delivered in […]
Being Patient: A Sensory Stimulation Headset for Alzheimer’s? A Neuropsychologist on the Clinical Trial
Could a headset with flashing lights and sounds stimulate brain waves and treat Alzheimer’s? Cognito’s Phase 3 trial on such a device is trying to answer that question. Neuropsychologist Dr. Michelle Papka, the trial’s principal investigator and founder of the CRCNJ, explains the science. Researchers and technology companies are investigating whether non-invasive electromagnetic, visual, and […]
News Medical: GAP collaborates with Biomarkers of Aging Consortium to advance Alzheimer’s research
The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for aging and longevity. Through a memorandum of understanding, the consortium, led by scholars from Harvard University, will gain early access to Bio-Hermes-001 data to investigate the potential for […]
KRGV: Volunteers in Rio Grande City study recognized for participating Alzheimer’s research
January 30, 2025 10:24 PM in News – Local By: Lily Celeste The Rio Grande Valley has one of the highest rates of Alzheimer’s in the country, and a clinic in Rio Grande city is attempting to find out why. Dina Ximenez said she’s been volunteering for three years for Alzheimer’s studies conducted by El Faro Health Clinic […]
Global Alzheimer’s Platform Foundation Announces Powerhouse Partnership with Biomarkers of Aging Consortium
Collaboration to accelerate the investigation of Alzheimer’s disease biomarkers with early access to Bio-Hermes-001 data Washington D.C., Jan. 30, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for aging and longevity. Through a memorandum […]
Tampa Bay Business Journal: Axiom Brain Health opens larger site for neurodegenerative disease research in Tampa
By Anjelica Rubin – Technology/Tampa Bay Inno reporter, Tampa Bay Business Journal Jan 27, 2025 Updated Jan 28, 2025 5:39pm EST Just over one year after being acquired to help build a clinical research center, Tampa-based Axiom Brain Health celebrated the next chapter in its neurodegenerative research at the launch of its new site on Jan. 23. The expansion […]